Research Diagnosis Related Groups (DRG) level Readmission quality outcomes for Encompass Health Rehabilitation Hospital of Salisbury located at 220 Tilghman Rd, Salisbury, MD, 21804 & includes data from NPIs 1164495867
*Readmission Rate is calculated from October 2016 to August 2019 and all other Quality Outcomes are calculated from October 2016 to September 2019.
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 4,068 | 3,651 | ||||||||||
| Neurology | 1,778 | 1,588 | ||||||||||
| Orthopedics | 1,357 | 1,256 | ||||||||||
| General Medicine | 266 | 229 | ||||||||||
| Cardiovascular | 265 | 224 | ||||||||||
| Pulmonology | 149 | 126 | ||||||||||
| Gastroenterology & Endocrinology | 77 | 69 | ||||||||||
| Urology | 61 | 54 | ||||||||||
| Oncology & Hematology | 54 | 46 | ||||||||||
| Dermatology | 35 | 34 | ||||||||||
| Spine | 13 | 12 |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nonspecific Cerebrovascular Disorders | ||||||||||||
| DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 070: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 072: NONSPECIFIC CEREBROVASCULAR DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Multiple Sclerosis And Cerebellar Ataxia | ||||||||||||
| DRG 060: MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 059: MULTIPLE SCLEROSIS AND CEREBELLAR ATAXIA WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
| Cranial And Peripheral Nerve Disorders | ||||||||||||
| DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 561: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 559: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Tendonitis, Myositis And Bursitis | ||||||||||||
| DRG 558: TENDONITIS, MYOSITIS AND BURSITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Bone Diseases And Arthropathies | ||||||||||||
| DRG 554: BONE DISEASES AND ARTHROPATHIES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Signs And Symptoms Of Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 556: SIGNS AND SYMPTOMS OF MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Musculoskeletal System And Connective Tissue Diagnoses | ||||||||||||
| DRG 566: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DIAGNOSES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Connective Tissue Disorders |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aftercare | ||||||||||||
| DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 950: AFTERCARE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Signs And Symptoms | ||||||||||||
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Injury, Poisoning And Toxic Effect Diagnoses | ||||||||||||
| DRG 923: OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| Disequilibrium | ||||||||||||
| DRG 149: DYSEQUILIBRIUM |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Heart Failure And Shock | ||||||||||||
| DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Atherosclerosis | ||||||||||||
| DRG 303: ATHEROSCLEROSIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| DRG 300: PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 301: PERIPHERAL VASCULAR DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| Cardiac Congenital And Valvular Disorders | ||||||||||||
| DRG 307: CARDIAC CONGENITAL AND VALVULAR DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 195: SIMPLE PNEUMONIA AND PLEURISY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Pleural Effusion |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| Other Digestive System Diagnoses |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Renal Failure |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nervous System Neoplasms | ||||||||||||
| DRG 055: NERVOUS SYSTEM NEOPLASMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trauma To The Skin, Subcutaneous Tissue And Breast | ||||||||||||
| DRG 605: TRAUMA TO THE SKIN, SUBCUTANEOUS TISSUE AND BREAST WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Maryland Total Hospitalizations (Oct 2016 to Sep 2019) | Maryland Total Hospitalizations After Exclusion | Maryland Total Users | Maryland Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Disorders And Injuries |